Opérations des initiés

EDGAR

NORTHROP GRUMMAN CORP /DE/

Opérations déclarées par les administrateurs, dirigeants et détenteurs de plus de 10 % sur les formulaires 3, 4 et 5 de la SEC, lues dans le XML de chaque dépôt. Les codes et leur libellé sont ceux de la SEC.

Le formulaire 4 doit être déposé dans les deux jours ouvrables suivant l’opération ; les plus récentes peuvent donc ne pas encore être déposées.

Période : opérations datées du 17 nov. 2025 ou après.

Achats sur le marché (code P)
0 opérations, — actions
Ventes sur le marché (code S)
66 opérations, 38 829,56 actions
Somme actions × prix par action : 26 481 336,9484

Les totaux additionnent les opérations déposées listées ; ils comptent ce qui a été déclaré et ne mesurent aucune direction.

Affichage de 1 à 50 sur 150

Opérations des initiés, les plus récentes d’abord, telles que déposées sur les formulaires 3, 4 et 5 de la SEC
DateDéclarantCodeAcquis ou cédéActionsPrix par action, tel que déposéValeur (calculée)Actions détenues aprèsDirecte ou indirecteCase de la règle 10b5-1NotesSource
2 nov. 2026 Déposé le 4 nov. 2026Davies Benjamin R. Officer: CVP Pres. Defense Systems
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquis (A)6410—792Directe (D) Non— Ouvrir le dépôt 0001628280-26-070174 Lu dans le XML du dépôt Contester cette ligne
2 nov. 2026 Déposé le 4 nov. 2026Davies Benjamin R. Officer: CVP Pres. Defense Systems
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Cédé (D)281555,32
156 044,92

Calculé : actions × prix par action. Valeur exacte 156044.92.

511Directe (D) Non— Ouvrir le dépôt 0001628280-26-070174 Lu dans le XML du dépôt Contester cette ligne
2 nov. 2026 Déposé le 4 nov. 2026Davies Benjamin R. Officer: CVP Pres. Defense Systems
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Titre dérivé: Restricted Stock Rights — sous-jacent Common Stock (641)
Cédé (D)6410—5 803Directe (D) Non
F2, F3, F4
  • F2 Each Restricted Stock Right (RSR) represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock.
  • F3 Shares issued upon vesting of RSRs granted under the 2011 Long-Term Incentive Stock Plan (2011 LTISP) on 11/1/23 that vested on 11/2/26.
  • F4 Total amount includes (i) 1,008 RSRs granted under the 2011 LTISP on 2/14/24 that will vest on 2/16/27; (ii) 638 RSRs granted under the 2011 LTISP on 7/31/24 that will vest on 8/2/27 ; (iii) 2,456 RSRs granted under the 2024 Long-Term Incentive Stock Plan (2024 LTISP) on 2/18/25 that will vest on 2/18/28; and (iv) 1,701 RSRs granted under the 2024 LTISP on 2/11/26 that will vest on 2/12/29.
Ouvrir le dépôt 0001628280-26-070174 Lu dans le XML du dépôt Contester cette ligne
2 nov. 2026 Déposé le 3 nov. 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)7553,39
3 873,73

Calculé : actions × prix par action. Valeur exacte 3873.73.

4 405Directe (D) Oui
F1, F2
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 27, 2026.
  • F2 Represents the weighted average sale price of $553.39 rounded to the nearest hundredth. The highest price at which the shares were sold was $553.80 and the lowest price at which the shares were sold was $553.19. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
Ouvrir le dépôt 0001628280-26-069214 Lu dans le XML du dépôt Contester cette ligne
2 nov. 2026 Déposé le 3 nov. 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)20554,48
11 089,6

Calculé : actions × prix par action. Valeur exacte 11089.60.

4 385Directe (D) Oui
F1, F3
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 27, 2026.
  • F3 Represents the weighted average sale price of $554.48 rounded to the nearest hundredth. The highest price at which the shares were sold was $554.99 and the lowest price at which the shares were sold was $554.01. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
Ouvrir le dépôt 0001628280-26-069214 Lu dans le XML du dépôt Contester cette ligne
2 nov. 2026 Déposé le 3 nov. 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)20555,46
11 109,2

Calculé : actions × prix par action. Valeur exacte 11109.20.

4 365Directe (D) Oui
F1, F4
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 27, 2026.
  • F4 Represents the weighted average sale price of $555.46 rounded to the nearest hundredth. The highest price at which the shares were sold was $555.89 and the lowest price at which the shares were sold was $555.03. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
Ouvrir le dépôt 0001628280-26-069214 Lu dans le XML du dépôt Contester cette ligne
2 nov. 2026 Déposé le 3 nov. 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)50556,47
27 823,5

Calculé : actions × prix par action. Valeur exacte 27823.50.

4 315Directe (D) Oui
F1, F5
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 27, 2026.
  • F5 Represents the weighted average sale price of $556.47 rounded to the nearest hundredth. The highest price at which the shares were sold was $556.60 and the lowest price at which the shares were sold was $556.03. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
Ouvrir le dépôt 0001628280-26-069214 Lu dans le XML du dépôt Contester cette ligne
2 nov. 2026 Déposé le 3 nov. 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)1557,47
557,47

Calculé : actions × prix par action. Valeur exacte 557.47.

4 314Directe (D) Oui
F1
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 27, 2026.
Ouvrir le dépôt 0001628280-26-069214 Lu dans le XML du dépôt Contester cette ligne
30 sept. 2026 Déposé le 1 oct. 2026KRISHNA ARVIND Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquis (A)75483,48
36 261

Calculé : actions × prix par action. Valeur exacte 36261.00.

2 837Directe (D) Non
F1, F2
  • F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
  • F2 Represents shares of common stock, including dividends, held in a stock unit account pursuant to the Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under rule 16a-11.
Ouvrir le dépôt 0001628280-26-064144 Lu dans le XML du dépôt Contester cette ligne
30 sept. 2026 Déposé le 1 oct. 2026Brown Marianne Catherine Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquis (A)96483,48
46 414,08

Calculé : actions × prix par action. Valeur exacte 46414.08.

11 706Directe (D) Non
F1, F2
  • F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
  • F2 Represents shares of common stock, including dividends, held in a stock unit account pursuant to the Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under rule 16a-11.
Ouvrir le dépôt 0001628280-26-064142 Lu dans le XML du dépôt Contester cette ligne
19 août 2026 Déposé le 21 août 2026Warden Kathy J Director · Officer: Chair, CEO and President
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Titre dérivé: Market Stock Units — sous-jacent Common Stock (35 910)
Acquis (A)35 9100—35 910Directe (D) Non
F1
  • F1 Each Market Stock Unit (MSU) represents the contingent right to receive, following vesting, between 0% and 150% of one share of the Issuer's common stock, subject to the Issuer's absolute stock price appreciation or depreciation over a performance period ending December 31, 2031. No portion of the MSUs will be earned if the Issuer's stock price depreciates by more than 25%, a 100% (or target) payout is earned if the Issuer's stock price appreciates by 10%, and a 150% payout is earned if the Issuer's stock price appreciates by 50% or more. The target number of MSUs is reported in this Report. Grant awarded pursuant to Rule 16b-3(d).
Ouvrir le dépôt 0001628280-26-058482 Lu dans le XML du dépôt Contester cette ligne
3 août 2026 Déposé le 4 août 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)8544,53
4 356,24

Calculé : actions × prix par action. Valeur exacte 4356.24.

4 480Directe (D) Oui
F1, F2
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
  • F2 Represents the weighted average sale price of $544.53 rounded to the nearest hundredth. The highest price at which the shares were sold was $544.81 and the lowest price at which the shares were sold was $544.03. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
Ouvrir le dépôt 0001628280-26-052370 Lu dans le XML du dépôt Contester cette ligne
3 août 2026 Déposé le 4 août 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)19545,59
10 366,21

Calculé : actions × prix par action. Valeur exacte 10366.21.

4 461Directe (D) Oui
F1, F3
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
  • F3 Represents the weighted average sale price of $545.59 rounded to the nearest hundredth. The highest price at which the shares were sold was $545.82 and the lowest price at which the shares were sold was $545.12. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
Ouvrir le dépôt 0001628280-26-052370 Lu dans le XML du dépôt Contester cette ligne
3 août 2026 Déposé le 4 août 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)11546,42
6 010,62

Calculé : actions × prix par action. Valeur exacte 6010.62.

4 450Directe (D) Oui
F1, F4
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
  • F4 Represents the weighted average sale price of $546.42 rounded to the nearest hundredth. The highest price at which the shares were sold was $546.89 and the lowest price at which the shares were sold was $546.05. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
Ouvrir le dépôt 0001628280-26-052370 Lu dans le XML du dépôt Contester cette ligne
3 août 2026 Déposé le 4 août 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)31547,42
16 970,02

Calculé : actions × prix par action. Valeur exacte 16970.02.

4 419Directe (D) Oui
F1, F5
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
  • F5 Represents the weighted average sale price of $547.42 rounded to the nearest hundredth. The highest price at which the shares were sold was $547.94 and the lowest price at which the shares were sold was $547.12. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
Ouvrir le dépôt 0001628280-26-052370 Lu dans le XML du dépôt Contester cette ligne
3 août 2026 Déposé le 4 août 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)10548,32
5 483,2

Calculé : actions × prix par action. Valeur exacte 5483.20.

4 409Directe (D) Oui
F1, F6
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
  • F6 Represents the weighted average sale price of $548.32 rounded to the nearest hundredth. The highest price at which the shares were sold was $548.78 and the lowest price at which the shares were sold was $548.11. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
Ouvrir le dépôt 0001628280-26-052370 Lu dans le XML du dépôt Contester cette ligne
3 août 2026 Déposé le 4 août 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)6549,50
3 297

Calculé : actions × prix par action. Valeur exacte 3297.00.

4 403Directe (D) Oui
F1, F7
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
  • F7 Represents the weighted average sale price of $549.50 rounded to the nearest hundredth. The highest price at which the shares were sold was $549.74 and the lowest price at which the shares were sold was $549.03. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
Ouvrir le dépôt 0001628280-26-052370 Lu dans le XML du dépôt Contester cette ligne
3 août 2026 Déposé le 4 août 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)2550,68
1 101,36

Calculé : actions × prix par action. Valeur exacte 1101.36.

4 401Directe (D) Oui
F1
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
Ouvrir le dépôt 0001628280-26-052370 Lu dans le XML du dépôt Contester cette ligne
3 août 2026 Déposé le 4 août 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)2552,95
1 105,9

Calculé : actions × prix par action. Valeur exacte 1105.90.

4 399Directe (D) Oui
F1
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
Ouvrir le dépôt 0001628280-26-052370 Lu dans le XML du dépôt Contester cette ligne
3 août 2026 Déposé le 4 août 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)2553,90
1 107,8

Calculé : actions × prix par action. Valeur exacte 1107.80.

4 397Directe (D) Oui
F1
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
Ouvrir le dépôt 0001628280-26-052370 Lu dans le XML du dépôt Contester cette ligne
3 août 2026 Déposé le 4 août 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)4554,14
2 216,56

Calculé : actions × prix par action. Valeur exacte 2216.56.

4 393Directe (D) Oui
F1, F8
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
  • F8 Represents the weighted average sale price of $554.14 rounded to the nearest hundredth. The highest price at which the shares were sold was $554.17 and the lowest price at which the shares were sold was $554.11. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
Ouvrir le dépôt 0001628280-26-052370 Lu dans le XML du dépôt Contester cette ligne
30 juin 2026 Déposé le 1 juil. 2026KRISHNA ARVIND Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquis (A)71509,31
36 161,01

Calculé : actions × prix par action. Valeur exacte 36161.01.

2 749Directe (D) Non
F1, F2
  • F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
  • F2 Represents shares of common stock, including dividends, held in a stock unit account pursuant to the Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under rule 16a-11.
Ouvrir le dépôt 0001628280-26-046449 Lu dans le XML du dépôt Contester cette ligne
30 juin 2026 Déposé le 1 juil. 2026Brown Marianne Catherine Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquis (A)91509,31
46 347,21

Calculé : actions × prix par action. Valeur exacte 46347.21.

11 558Directe (D) Non
F1, F2
  • F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
  • F2 Represents shares of common stock, including dividends, held in a stock unit account pursuant to the Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under rule 16a-11.
Ouvrir le dépôt 0001628280-26-046450 Lu dans le XML du dépôt Contester cette ligne
20 mai 2026 Déposé le 21 mai 2026SCHOEWE THOMAS M Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquis (A)349552,17
192 707,33

Calculé : actions × prix par action. Valeur exacte 192707.33.

16 737Directe (D) Non
F1, F2
  • F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
  • F2 Amount includes (i) 3,160 shares of common stock; and (ii) 13,577 shares of common stock, including dividends, held in a stock unit account pursuant to the Plan and the Northrop Grumman 2011 Long-Term Incentive Stock Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under Rule 16a-11.
Ouvrir le dépôt 0001628280-26-037205 Lu dans le XML du dépôt Contester cette ligne
20 mai 2026 Déposé le 21 mai 2026Brown Marianne Catherine Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquis (A)349552,17
192 707,33

Calculé : actions × prix par action. Valeur exacte 192707.33.

11 415Directe (D) Non
F1, F2
  • F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
  • F2 Represents shares of common stock, including dividends, held in a stock unit account pursuant to the Plan and the Northrop Grumman 2011 Long-Term Incentive Stock Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under rule 16a-11.
Ouvrir le dépôt 0001628280-26-037195 Lu dans le XML du dépôt Contester cette ligne
20 mai 2026 Déposé le 21 mai 2026Turley James S Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquis (A)349552,17
192 707,33

Calculé : actions × prix par action. Valeur exacte 192707.33.

6 738Directe (D) Non
F1, F2
  • F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
  • F2 Amount includes (i) 635 shares of common stock; and (ii) 6,103 shares of common stock, including dividends, held in a stock unit account pursuant to the Plan and the Northrop Grumman 2011 Long-Term Incentive Stock Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under Rule 16a-11.
Ouvrir le dépôt 0001628280-26-037207 Lu dans le XML du dépôt Contester cette ligne
20 mai 2026 Déposé le 21 mai 2026ABNEY DAVID P Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquis (A)349552,17
192 707,33

Calculé : actions × prix par action. Valeur exacte 192707.33.

2 824Directe (D) Non
F1, F2
  • F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
  • F2 Amount includes (i) 2,475 shares of common stock; and (ii) 349 shares of common stock, including dividends, held in a stock unit account pursuant to the Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under Rule 16a-11.
Ouvrir le dépôt 0001628280-26-037192 Lu dans le XML du dépôt Contester cette ligne
20 mai 2026 Déposé le 21 mai 2026KRISHNA ARVIND Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquis (A)349552,17
192 707,33

Calculé : actions × prix par action. Valeur exacte 192707.33.

2 666Directe (D) Non
F1, F2
  • F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
  • F2 Represents shares of common stock, including dividends, held in a stock unit account pursuant to the Plan and the Northrop Grumman 2011 Long-Term Incentive Stock Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under rule 16a-11.
Ouvrir le dépôt 0001628280-26-037199 Lu dans le XML du dépôt Contester cette ligne
20 mai 2026 Déposé le 21 mai 2026Ross Kimberly A. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquis (A)349552,17
192 707,33

Calculé : actions × prix par action. Valeur exacte 192707.33.

1 612Directe (D) Non
F1, F2
  • F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
  • F2 Represents shares of common stock, including dividends, held in a stock unit account pursuant to the Plan and the Northrop Grumman 2011 Long-Term Incentive Stock Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under rule 16a-11.
Ouvrir le dépôt 0001628280-26-037201 Lu dans le XML du dépôt Contester cette ligne
20 mai 2026 Déposé le 21 mai 2026WINSTON MARY A Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquis (A)349552,17
192 707,33

Calculé : actions × prix par action. Valeur exacte 192707.33.

1 609Directe (D) Non
F1, F2
  • F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
  • F2 Amount includes (i) 78 shares of common stock; and (ii) 1,540 shares of common stock, including dividends, held in a stock unit account pursuant to the Plan and the Northrop Grumman 2011 Long-Term Incentive Stock Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under Rule 16a-11.
Ouvrir le dépôt 0001628280-26-037211 Lu dans le XML du dépôt Contester cette ligne
20 mai 2026 Déposé le 21 mai 2026Grady Christopher W. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquis (A)349552,17
192 707,33

Calculé : actions × prix par action. Valeur exacte 192707.33.

421Directe (D) Non
F1, F2
  • F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
  • F2 Represents shares of common stock, including dividends, held in a stock unit account pursuant to the Plan and the Northrop Grumman 2024 Long-Term Incentive Stock Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under rule 16a-11.
Ouvrir le dépôt 0001628280-26-037197 Lu dans le XML du dépôt Contester cette ligne
20 mai 2026 Déposé le 21 mai 2026WELSH MARK A III Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquis (A)349552,17
192 707,33

Calculé : actions × prix par action. Valeur exacte 192707.33.

4 470Directe (D) Non
F1, F2
  • F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
  • F2 Amount includes (i) 488 shares of common stock; and (ii) 3,982 shares of common stock, including dividends, held in a stock unit account pursuant to the Plan and the Northrop Grumman 2011 Long-Term Incentive Stock Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under Rule 16a-11.
Ouvrir le dépôt 0001628280-26-037209 Lu dans le XML du dépôt Contester cette ligne
20 mai 2026 Déposé le 21 mai 2026ROUGHEAD GARY Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquis (A)349552,17
192 707,33

Calculé : actions × prix par action. Valeur exacte 192707.33.

12 210Directe (D) Non
F1, F2
  • F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
  • F2 Represents shares of common stock, including dividends, held in a stock unit account pursuant to the Plan and the Northrop Grumman 2011 Long-Term Incentive Stock Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under rule 16a-11.
Ouvrir le dépôt 0001628280-26-037203 Lu dans le XML du dépôt Contester cette ligne
4 mai 2026 Déposé le 5 mai 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)1566,60
566,6

Calculé : actions × prix par action. Valeur exacte 566.60.

4 215Directe (D) Oui
F1
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
Ouvrir le dépôt 0001628280-26-030668 Lu dans le XML du dépôt Contester cette ligne
4 mai 2026 Déposé le 5 mai 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)5568,75
2 843,75

Calculé : actions × prix par action. Valeur exacte 2843.75.

4 210Directe (D) Oui
F1, F2
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
  • F2 Represents the weighted average sale price of $568.75 rounded to the nearest hundredth. The highest price at which the shares were sold was $568.92 and the lowest price at which the shares were sold was $568.49. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
Ouvrir le dépôt 0001628280-26-030668 Lu dans le XML du dépôt Contester cette ligne
4 mai 2026 Déposé le 5 mai 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)9569,49
5 125,41

Calculé : actions × prix par action. Valeur exacte 5125.41.

4 201Directe (D) Oui
F1, F3
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
  • F3 Represents the weighted average sale price of $569.49 rounded to the nearest hundredth. The highest price at which the shares were sold was $569.97 and the lowest price at which the shares were sold was $569.01. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
Ouvrir le dépôt 0001628280-26-030668 Lu dans le XML du dépôt Contester cette ligne
4 mai 2026 Déposé le 5 mai 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)43570,47
24 530,21

Calculé : actions × prix par action. Valeur exacte 24530.21.

4 158Directe (D) Oui
F1, F4
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
  • F4 Represents the weighted average sale price of $570.47 rounded to the nearest hundredth. The highest price at which the shares were sold was $570.84 and the lowest price at which the shares were sold was $570.25. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
Ouvrir le dépôt 0001628280-26-030668 Lu dans le XML du dépôt Contester cette ligne
4 mai 2026 Déposé le 5 mai 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)3571,74
1 715,22

Calculé : actions × prix par action. Valeur exacte 1715.22.

4 155Directe (D) Oui
F1, F5
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
  • F5 Represents the weighted average sale price of $571.74 rounded to the nearest hundredth. The highest price at which the shares were sold was $571.98 and the lowest price at which the shares were sold was $571.32. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
Ouvrir le dépôt 0001628280-26-030668 Lu dans le XML du dépôt Contester cette ligne
4 mai 2026 Déposé le 5 mai 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)6572,72
3 436,32

Calculé : actions × prix par action. Valeur exacte 3436.32.

4 149Directe (D) Oui
F1, F6
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
  • F6 Represents the weighted average sale price of $572.72 rounded to the nearest hundredth. The highest price at which the shares were sold was $572.98 and the lowest price at which the shares were sold was $572.51. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
Ouvrir le dépôt 0001628280-26-030668 Lu dans le XML du dépôt Contester cette ligne
4 mai 2026 Déposé le 5 mai 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)14573,51
8 029,14

Calculé : actions × prix par action. Valeur exacte 8029.14.

4 135Directe (D) Oui
F1, F7
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
  • F7 Represents the weighted average sale price of $573.51 rounded to the nearest hundredth. The highest price at which the shares were sold was $573.80 and the lowest price at which the shares were sold was $573.14. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
Ouvrir le dépôt 0001628280-26-030668 Lu dans le XML du dépôt Contester cette ligne
4 mai 2026 Déposé le 5 mai 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)2574,51
1 149,02

Calculé : actions × prix par action. Valeur exacte 1149.02.

4 133Directe (D) Oui
F1, F8
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
  • F8 Represents the weighted average sale price of $574.51 rounded to the nearest hundredth. The highest price at which the shares were sold was $574.66 and the lowest price at which the shares were sold was $574.35. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
Ouvrir le dépôt 0001628280-26-030668 Lu dans le XML du dépôt Contester cette ligne
4 mai 2026 Déposé le 5 mai 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)4575,59
2 302,36

Calculé : actions × prix par action. Valeur exacte 2302.36.

4 129Directe (D) Oui
F1, F9
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
  • F9 Represents the weighted average sale price of $575.59 rounded to the nearest hundredth. The highest price at which the shares were sold was $575.99 and the lowest price at which the shares were sold was $575.38. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
Ouvrir le dépôt 0001628280-26-030668 Lu dans le XML du dépôt Contester cette ligne
4 mai 2026 Déposé le 5 mai 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)7576,38
4 034,66

Calculé : actions × prix par action. Valeur exacte 4034.66.

4 122Directe (D) Oui
F1, F10
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
  • F10 Represents the weighted average sale price of $576.38 rounded to the nearest hundredth. The highest price at which the shares were sold was $576.87 and the lowest price at which the shares were sold was $576.03. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
Ouvrir le dépôt 0001628280-26-030668 Lu dans le XML du dépôt Contester cette ligne
4 mai 2026 Déposé le 5 mai 2026WELSH MARK A III Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)1577,05
577,05

Calculé : actions × prix par action. Valeur exacte 577.05.

4 121Directe (D) Oui
F1
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
Ouvrir le dépôt 0001628280-26-030668 Lu dans le XML du dépôt Contester cette ligne
31 mars 2026 Déposé le 2 avr. 2026KRISHNA ARVIND Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquis (A)53682,24
36 158,72

Calculé : actions × prix par action. Valeur exacte 36158.72.

2 317Directe (D) Non
F1, F2
  • F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
  • F2 Represents shares of common stock, including dividends, held in a stock unit account pursuant to the Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under rule 16a-11.
Ouvrir le dépôt 0001628280-26-022974 Lu dans le XML du dépôt Contester cette ligne
31 mars 2026 Déposé le 2 avr. 2026Brown Marianne Catherine Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquis (A)68682,24
46 392,32

Calculé : actions × prix par action. Valeur exacte 46392.32.

11 066Directe (D) Non
F1, F2
  • F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
  • F2 Represents shares of common stock, including dividends, held in a stock unit account pursuant to the Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under rule 16a-11.
Ouvrir le dépôt 0001628280-26-022976 Lu dans le XML du dépôt Contester cette ligne
2 mars 2026 Déposé le 3 mars 2026Simpson Kathryn G Officer: Corp VP General Counsel
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)873745
650 385

Calculé : actions × prix par action. Valeur exacte 650385.

1,39Directe (D) Oui
F1
  • F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2025.
Ouvrir le dépôt 0001628280-26-013772 Lu dans le XML du dépôt Contester cette ligne
27 févr. 2026 Déposé le 2 mars 2026ROEDER ROSHAN S Officer: CVP Pres. Mission Systems
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)1 754720
1 262 880

Calculé : actions × prix par action. Valeur exacte 1262880.

2 353,39Directe (D) Oui
F1
  • F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025.
Ouvrir le dépôt 0001628280-26-013201 Lu dans le XML du dépôt Contester cette ligne
19 févr. 2026 Déposé le 20 févr. 2026Simpson Kathryn G Officer: Corp VP General Counsel
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)194727,62
141 158,28

Calculé : actions × prix par action. Valeur exacte 141158.28.

874,39Directe (D) Oui
F1
  • F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2025.
Ouvrir le dépôt 0001628280-26-010367 Lu dans le XML du dépôt Contester cette ligne
19 févr. 2026 Déposé le 20 févr. 2026Hardesty Michael A Officer: Corp VP, Controller CAO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)147732,98
107 748,06

Calculé : actions × prix par action. Valeur exacte 107748.06.

2 525,29Directe (D) Non— Ouvrir le dépôt 0001628280-26-010262 Lu dans le XML du dépôt Contester cette ligne

Détenteurs institutionnels (formulaire 13F)

Aucune position du formulaire 13F n’est rattachée à cet émetteur dans le magasin. Un détenteur non encore rattaché ou n’ayant pas encore déposé est absent, pas à zéro.

Détenteurs de 5 % (annexes 13D et 13G)

Les annexes déposées au format structuré de la SEC (depuis fin 2024) sont lues ici. Les précédentes sont en texte libre et ne sont pas lues.

Détenteurs de 5 %, événement le plus récent d’abord, tels que déposés
DétenteurPourcentage de la catégorieActions détenuesDate de l’événementFormulaireSource
Capital International Investors Common Stock4.36 044 489,0006/30/2026 Déposé le 12 août 2026SCHEDULE 13G/AModification 10Ouvrir le dépôt 0001562230-26-000127 Contester cette ligne
Capital International Investors Common Stock5.27 321 667,0003/31/2026 Déposé le 14 mai 2026SCHEDULE 13G/AModification 9Ouvrir le dépôt 0001562230-26-000095 Contester cette ligne
Vanguard Capital Management Common Stock7.2210 248 54003/31/2026 Déposé le 30 avr. 2026SCHEDULE 13GOuvrir le dépôt 0002100119-26-000866 Contester cette ligne
The Vanguard Group Common Stock0003/13/2026 Déposé le 27 mars 2026SCHEDULE 13G/AModification 12Ouvrir le dépôt 0000102909-26-001945 Contester cette ligne
Capital International Investors Common Stock8.612 385 281,0006/30/2025 Déposé le 13 août 2025SCHEDULE 13G/AModification 8Ouvrir le dépôt 0001562230-25-000110 Contester cette ligne

Le pourcentage porte sur la catégorie que nomme le dépôt, tel que l’a déclaré le détenteur. Les membres d’un groupe déclarent chacun les actions du groupe ; les lignes ne s’additionnent donc pas.

Ce qui a été lu

2 195 806 dépôts lus, datés du 14 juin 2004 au 16 nov. 2026 : formulaires 3, 3/A, 4, 4/A, 5, 5/A.

Certaines années peuvent être incomplètes tant que l’archive est en cours de lecture. Une année avec peu de dépôts ici n’affirme pas qu’il y en a eu peu.

Dépôts lus, par année de dépôt
Année de dépôtDépôts lus
20151
2016204 322
2017202 494
2018202 048
2019193 638
2020144 184
2021224 474
2022113 548
2023199 811
2024209 823
2025235 520
2026260 165

Les dépôts antérieurs à l’obligation du XML par la SEC sont listés, non extraits.

Retour à NORTHROP GRUMMAN CORP /DE/